相关实验视频

Updated: Jun 30, 2025

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on: February 6, 2017

通过T细胞识别单态MHC I类相关蛋白MR1的T细胞识别来准儿科癌症

Annelisa M Cornel^1,2, Loutje van der Sman^1,2, Jip T van Dinter²

¹Prinses Maxima Centrum voor Kinderoncologie, Utrecht, The Netherlands.

Journal for immunotherapy of cancer

|March 22, 2024

概括

这项研究探讨了针对儿科癌症的MR1-T细胞疗法. 虽然对白血病和质瘤有效,但由于MR1表达率低,胚胎瘤的反应有限.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

由于人类白细胞抗原 (HLA) 的限制,T细胞疗法面临着挑战.
非典型的MR1-受限T细胞识别MR1-呈现的癌症代谢物,提供潜在的泛癌症免疫疗法.
之前的研究集中在成人恶性瘤,留下了未经探索的儿科应用.

研究的目的:

研究MR1向细胞治疗在儿童癌症中的潜力.
在初级儿科瘤中评估MR1表达.
评估MC.7.G5MR1T-克隆对儿科癌症模型的疗效.

主要方法:

分析来自小儿原发性瘤的大量RNA测序数据,以评估MR1的表达.
在试管婴儿瘤模型中选工程MC.7.G5TCR表达T细胞的敏感性.
准能力与基于qPCR的MR1mRNA和蛋白质过度表达的相关性.

主要成果:

在儿童瘤类型和实体内,MR1 RNA表达有显著的差异.
与其他儿科瘤相比,胚胎瘤的MR1表达显著降低.
在体外研究表明,MR1T在儿科白血病和扩散中线质瘤模型中的敏感性,但对胚胎瘤的活性有限.

结论:

MC.7.G5 MR1T细胞免疫疗法在儿童白血病和扩散中线质瘤方面显示出前景.
对胚胎瘤的活性有限,可能是由于MR1表达率低.
这种方法可以提高复发性/耐药性白血病和高级脑瘤的儿童的生存率.

关键词:

细胞工程细胞工程免疫疗法免疫疗法儿科儿科儿科儿科

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain

Published on: October 25, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...